<DOC>
	<DOCNO>NCT02657460</DOCNO>
	<brief_summary>The study investigate anticancer effect relate immunological mechanism MTX-ATMPs treatment malignant pleural effusion .</brief_summary>
	<brief_title>Clinical Trial Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs Treat Malignant Pleural Effusion</brief_title>
	<detailed_description>Malignant pleural effusion ( MPE ) common complication advance lung cancer lack efficient treatment . The investigator successfully produce tumor cell-derived microparticles package chemotherapy drug confirm new integrative target biochemotherapy treatment could effectively restrain tumor growth cellular animal levels.This new method could control tumor growth vivo effectively induced pleural adhesion early clinical study . So investigators attempt explore anticancer effect relate immune regulation mechanism methotrexate-autologous tumor derive microparticles ( MTX-ATMPs ) MPE treatment . The tumor cell malignant pleural effusion prepare screening , MTX-ATMPs make . Participants enrol randomly assign experimental control group , inject prepared drug two day malignant pleural effusion disappear treatment cycle six time . During whole treatment , reaction treatment participant carefully follow .</detailed_description>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . The diagnosis lung cancer malignant pleural effusion confirm pathology / pleural fluid cytology ; 2 . The routine surgery systemic radio/chemotherapy ineffective , MPE relapse , routine treatment therapy give selfcauses ; 3. stable vital sign KPS ( Karnofsky Performance Status ) index 60 ; 4 . 1870 year old ; 5. normal haematopoietic function bone marrow , hemorrhagic tendency , blood routine test : HGB &gt; =100g/L , WBC &gt; 4.0*10^9/L , PLT &gt; 80*10^9/L , serum ALT , AST within 2 time upper limit normal , BUN within 1.5 time upper limit normal , creatinine within normal range , normal EKG ; 6. agree participate study sign inform consent ; 7. without severe comorbidities . 1. lactate pregnant patient ; 2. allergy multiple drug ; 3. severe comorbidities psychological disease ; 4. severe infection ; 5. participation clinical trial within recent three month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>chemotherapy</keyword>
	<keyword>microparticle</keyword>
	<keyword>malignant pleural effusion</keyword>
</DOC>